Introduced in the 1980s, carbapenem antibiotics have served as the last line of defense
against multidrug‐resistant Gram‐negative organisms. Over the last decade, carbapenem …

The Centers for Disease Control and Prevention (CDC) defines carbapenem-resistant
Enterobacteriaceae (CRE) based upon a phenotypic demonstration of carbapenem …

Background Acinetobacter baumannii is an opportunistic pathogen that rapidly develops
antibiotic resistance against commonly prescribed antimicrobial agents in hospitalized …

Antimicrobial resistance in carbapenem non-susceptible Acinetobacter baumannii (CNSAb)
is a major public health concern globally. This study determined the antibiotic resistance and …

Background In hospital settings, restriction of selected classes of antibiotics is usually
believed to contribute to containment of resistance development. We performed a systematic …

Antibiotic usage and increasing antimicrobial resistance (AMR) mount significant challenges
to patient safety and management of the critically ill on intensive care units (ICU). Antibiotic …

Abstract Background China's Ministry of Health (MOH) has established a policy about the
antimicrobial stewardship. To date, the effects of this policy on multidrug-resistant organism …

This study aimed to assess whether post-prescription review and feedback (PPRF) of all
antibiotics, with restriction of carbapenems, fluoroquinolones and third-generation …

Objective To evaluate the clinical and financial impact of clinical pharmacists' interventions
(CPIs) on antimicrobial use at a 500-bed multidisciplinary tertiary care hospital in Oman …

Objectives There are many studies about Iranian clinical pharmacists' interventions and their
impacts on medication safety and cost. The aim of this study is to collect data and critically …